Will Imaging Assist in the Selection of Patients With Heart Failure for an ICD?

JACC: Cardiovascular Imaging

Volumn 3, Issue 1, 2010, Pages 101-110

  Gerson, Myron C ^a,b   Abdallah, Mouhamad ^a   Muth, James N ^a   Costea, Alexandru I ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

11C hydroxyephedrine; 123I meta iodobenzylguanidine; cardiac magnetic resonance; heart failure; implanted cardioverter defibrillator; sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON 11; GADOLINIUM;

ADRENERGIC SYSTEM; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART INFARCTION SIZE; HEART INNERVATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; SYMPATHETIC INNERVATION; TREATMENT INDICATION;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DIAGNOSTIC IMAGING; ELECTRIC COUNTERSHOCK; HEART; HEART FAILURE; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; TREATMENT OUTCOME;

EID: 73649140660     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.07.013     Document Type: Review

References (55)

1. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
2. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). J Am Coll Cardiol 51 (2008) 2085-2105
3. Stecker E.C., Vickers C., Waltz J., et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction. Two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 47 (2006) 1161-1166
4. Goldberger J.J., Cain M.E., Hohnloser S.H., et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 30 (2008) 1179-1199
5. Bello D., Fieno D.S., Kim R.J., et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45 (2005) 1104-1108
6. Elhendy A., Schinkel A.F.L., van Domburg R.T., Bax J.J., and Poldermans D. Prognostic significance of fixed perfusion abnormalities on stress technetium-99m sestamibi single-photon emission computed tomography in patients without known coronary artery disease. Am J Cardiol 92 (2003) 1165-1170
7. Iskander S., and Iskandrian A.E. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 32 (1998) 57-62
8. Morishima I., Sone T., Tsuboi H., et al. Risk stratification of patients with prior myocardial infarction and advanced left ventricular dysfunction by gated myocardial perfusion SPECT imaging. J Nucl Cardiol 15 (2008) 631-637
9. Wu T.-J., Ong J.J.C., Hwang C., et al. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. J Am Coll Cardiol 32 (1998) 187-196
10. Assomull R.G., Prasad S.K., Lyne J., et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1977-1985
11. Wu K.C., Weiss R.G., Thiemann D.R., et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51 (2008) 2414-2421
12. Canty Jr. J.M., Suzuki G., Banas M.D., Verheyen F., Borgers M., and Fallavollita J.A. Hibernating myocardium. Chronically adapted to ischemia but vulnerable to sudden death. Circ Res 94 (2004) 1142-1149
13. Hoque A., Maaieh M., Longaker R.A., and Stoddard M.F. Exercise echocardiography and thallium-201 single-photon emission computed tomography stress test for 5- and 10-year prognosis of mortality and specific cardiac events. J Am Soc Echocardiogr 15 (2002) 1326-1334
14. Manolis A.S., Rastegar H., and Estes III N.A. Effects of coronary artery bypass grafting on ventricular arrhythmias: results with electrophysiological testing and long-term follow-up. Pacing Clin Electrophysiol 16 (1993) 984-991
15. Every N.R., Fahrenbruch C.E., Hallstrom A.P., Weaver W.D., and Cobb L.A. Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. J Am Coll Cardiol 19 (1992) 1435-1439
16. van der Burg A.E.B., Bax J.J., Boersma E., Pauwels E.K.J., van der Wall E.E., and Schalij M.J. Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death. Circulation 108 (2003) 1954-1959
17. Elhendy A., Chapman S., Porter T.R., and Windle J. Association of myocardial ischemia with mortality and implantable cardioverter-defibrillator therapy in patients with coronary artery disease at risk of arrhythmic death. J Am Coll Cardiol 46 (2005) 1721-1726
18. Bigger Jr. J.T., and Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 337 (1997) 1569-1575
19. Schmidt A., Azevedo C.F., Cheng A., et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115 (2007) 2006-2014
20. Piccini J.P., Horton J.R., Shaw L.K., et al. Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death. Circ Cardiovasc Imaging 1 (2008) 180-188
21. Yan A.T., Shayne A.J., Brown K.A., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114 (2006) 32-39
22. Stanton M.S., and Zipes D.P. Modulation of drug effects by regional sympathetic denervation and supersensitivity. Circulation 84 (1991) 1709-1714
23. Gerson M.C., Craft L.L., McGuire N., et al. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine. J Nucl Cardiol 9 (2002) 608-615
24. 123I-meta-iodobenzylguanidine scintigraphy. Circulation 89 (1994) 667-683
25. Sasano T., Abraham R., Chang K.-C., et al. Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 51 (2008) 2266-2275
26. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311 (1984) 819-823
27. Kaye D.M., Lefkovits J., Jennings G.L., Bergin P., Broughton A., and Esler M.D. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26 (1995) 1257-1263
28. 2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load. Circ Res 102 (2008) 1389-1397
29. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 48 (2006) 1064-1108
30. Merlet P., Benvenuti C., Moyse D., et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 40 (1999) 917-923
31. Terai H., Shimizu M., Ino H., et al. Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias. J Nucl Cardiol 10 (2003) 304-310
32. Akutsu Y., Kaneko K., Kodama Y., et al. The significance of cardiac sympathetic nervous system abnormality in the long-term prognosis of patients with a history of ventricular tachyarrhythmia. J Nucl Med 50 (2009) 61-67
33. Akutsu Y., Kaneko K., Kodama Y., et al. Cardiac sympathetic nerve abnormality predicts ventricular tachyarrhythmic events in patients without conventional risk of sudden death. Eur J Nucl Med Mol Imaging 35 (2008) 2066-2073
34. 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med 40 (1999) 1-5
35. Paul M., Schafers M., Kies P., et al. Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation. Eur J Nucl Med Mol Imaging 33 (2006) 866-870
36. Arora R., Ferrick K.J., Nakata T., et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol 10 (2003) 121-131
37. Nagahara D., Nakata T., Hashimoto A., et al. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function. J Nucl Med 49 (2008) 225-233
38. Kioka H., Yamada T., Mine T., et al. Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging. Heart 93 (2007) 1213-1218
39. Agostini D., Verberne H.J., Burchert W., et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 35 (2008) 535-546
40. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials. J Nucl Cardiol 16 (2009) 113-121
41. Zipes D.P. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 82 (1990) 1095-1105
42. 99mTc-MIBI and late ventricular potentials in patients after myocardial infarction: association with the development of ventricular arrhythmias. Am Heart J 136 (1998) 859-867
43. Hayashi M., Kobayashi Y., Morita N., et al. Clinical significance and contributing factors of long-term variability in induced ventricular tachyarrhythmias. J Cardiovasc Electrophysiol 14 (2003) 1049-1056
44. Miller W.L., Tointon S.K., Hodge D.O., Nelson S.M., Rodeheffer R.J., and Gibbons R.J. Long-term outcome and the use of revascularization in patients with heart failure, suspected ischemic heart disease, and large reversible myocardial perfusion defects. Am Heart J 143 (2002) 904-909
45. Podio V., Spinnler M.T., Bertuccio G., Carbonero C., Pelosi E., and Bisi G. Prognosis of hibernating myocardium is independent of recovery of function: evidence from a routine based follow-up study. Nucl Med Commun 23 (2002) 933-942
46. Fallavollita J.A., Luisi Jr. A.J., Michalek S.M., et al. Prediction of arrhythmic events with positron emission tomography: PAREPET study design and methods. Contemp Clin Trials 27 (2006) 374-388
47. Mitrani R.D., Klein L.S., Miles W.M., et al. Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 22 (1993) 1344-1353
48. Calkins H., Allman K., Bolling S., et al. Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart. Circulation 88 (1993) 172-179
49. Anastasiou-Nana M.I., Terrovitis J.V., Athanasoulis T., et al. Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 96 (2005) 427-431
50. Yamada T., Shimonagata T., Fukunami M., et al. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure. A prospective study. J Am Coll Cardiol 41 (2003) 231-238
51. Tamaki S., Yamada T., Okuyama Y., et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol 53 (2009) 426-435
52. Mantysaari M., Kuikka J., Hartikainen J., et al. Myocardial sympathetic nervous dysfunction detected with iodine-123-MIBG is associated with low heart rate variability after myocardial infarction. J Nucl Med 36 (1995) 956-961
53. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden cardiac death in patients with chronic heart failure. Circulation 105 (2002) 2392-2397
54. Caldwell J.H., Link J.M., Levy W.C., Poole J.E., and Stratton J.R. Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med 49 (2008) 234-241
55. van der Burg A.E.B., Bax J.J., Boersma E., et al. Standardized screening and treatment of patients with life-threatening arrhythmias: the Leiden Out-of-Hospital Cardiac Arrest Evaluation study. Heart Rhythm 1 (2004) 51-57